INS and diabetes mellitus: Consistent with the heterogenous nature of the etiology of diabetes, these treatments elicit their therapeutic effects via modulation of different metabolic pathways such as insulin sensitivity [1], renal glucose reabsorption [2], glucose-dependent insulin secretion [3], and hepatic glucose production [4].